Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Ann Oncol
.
2015 Sep:26 Suppl 5:v133-8.
doi: 10.1093/annonc/mdv305.
Authors
K Fizazi
1
,
F A Greco
2
,
N Pavlidis
3
,
G Daugaard
4
,
K Oien
5
,
G Pentheroudakis
3
;
ESMO Guidelines Committee
Collaborators
ESMO Guidelines Committee
:
Andrés Cervantes
,
George Pentheroudakis
,
Nicholas Pavlidis
,
Rolf A Stahel
,
Fatima Cardoso
,
Elzbieta Senkus-Konefka
,
Dirk Arnold
,
Alan Horwich
,
Cristiana Sessa
,
Nicoletta Colombo
,
Lisa Licitra
,
Christian Buske
,
Marco Ladetto
,
Solange Peters
,
Jean-Yves Blay
,
Ulrich Keilholz
,
Florian Strasser
,
Azza Adel Hassan
,
Jørn Herrstedt
,
Keith H McGregor
,
Claire Bramley
,
Jennifer Lamarre
,
Matthew Wallace
,
Aude Galli
,
Svetlana Jezdic
Affiliations
1
Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France.
2
Tennessee Oncology, Centennial Medical Center, Nashville, USA.
3
Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
4
Department of Oncology 5073, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
5
University of Glasgow, Institute of Cancer Sciences, Glasgow, UK.
PMID:
26314775
DOI:
10.1093/annonc/mdv305
No abstract available
Publication types
Practice Guideline
MeSH terms
Humans
Neoplasms, Unknown Primary* / diagnosis
Neoplasms, Unknown Primary* / pathology
Neoplasms, Unknown Primary* / therapy